This report aims to provide a comprehensive study of the global market for Brucella Melitensis Vaccine.
Report Highlights:
(1) Global Brucella Melitensis Vaccine market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Brucella Melitensis Vaccine market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Brucella Melitensis Vaccine market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Brucella Melitensis Vaccine segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Brucella Melitensis Vaccine segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Brucella Melitensis Vaccine, capacity, production and trends.
(7) Brucella Melitensis Vaccine industry supply chain, upstream, midstream and downstream analysis.
According to Latest Research, the global market for Brucella Melitensis Vaccine should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Brucella Melitensis Vaccine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Brucella Melitensis Vaccine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Live Vaccines segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Commercial Farming Enterprise has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Brucella Melitensis Vaccine include CZ Veterinaria, JOVAC, Dollvet, Antigen, Jinyu, Onderstepoort, VETAL Animal Health Products Inc., MSD Animal Health and Hester Biosciences Limited, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
By Product Type, the market is primarily segmented into:
Live Vaccines
Attenuated Vaccines
By Applications, the market is segmented into:
Commercial Farming Enterprise
Private Farming
Key Players Driving the Market:
CZ Veterinaria
JOVAC
Dollvet
Antigen
Jinyu
Onderstepoort
VETAL Animal Health Products Inc.
MSD Animal Health
Hester Biosciences Limited
1 Market Overview
1.1 Brucella Melitensis Vaccine Definition
1.2 Global Brucella Melitensis Vaccine Market Size and Forecast
1.2.1 By Revenue, Global Brucella Melitensis Vaccine Market Size, 2018-2029
1.2.2 By Sales Volume, Global Brucella Melitensis Vaccine Market Size, 2018-2029
1.2.3 Global Brucella Melitensis Vaccine Price Trend, 2018-2029
1.3 China Brucella Melitensis Vaccine Market Size and Forecast
1.3.1 By Revenue, China Brucella Melitensis Vaccine Market Size, 2018-2029
1.3.2 By Sales Volume, China Brucella Melitensis Vaccine Market Size, 2018-2029
1.3.3 China Brucella Melitensis Vaccine Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Brucella Melitensis Vaccine Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Brucella Melitensis Vaccine Share in Global Market, 2018-2029
1.4.3 Brucella Melitensis Vaccine Market Size: China VS Global, 2018-2029
1.5 Brucella Melitensis Vaccine Market Dynamics
1.5.1 Brucella Melitensis Vaccine Market Drivers
1.5.2 Brucella Melitensis Vaccine Market Restraints
1.5.3 Brucella Melitensis Vaccine Industry Trends
1.5.4 Brucella Melitensis Vaccine Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Brucella Melitensis Vaccine Revenue by Company, 2018-2023
2.2 Global Brucella Melitensis Vaccine Sales Volume by Company, 2018-2023
2.3 Global Brucella Melitensis Vaccine Price by Company, 2018-2023
2.4 Global Brucella Melitensis Vaccine Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Brucella Melitensis Vaccine Concentration Ratio
2.6 Global Brucella Melitensis Vaccine Mergers & Acquisitions, Expansion Plans
2.7 Global Brucella Melitensis Vaccine Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Brucella Melitensis Vaccine Revenue by Company, 2018-2023
3.2 China Brucella Melitensis Vaccine Sales Volume by Company, 2018-2023
3.3 China Brucella Melitensis Vaccine Brucella Melitensis Vaccine Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Brucella Melitensis Vaccine Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Brucella Melitensis Vaccine Domestic VS Export
3.6 China Market, Brucella Melitensis Vaccine Import & Export
3.6.1 China Market, Brucella Melitensis Vaccine Import & Export, 2018-2029
3.6.2 China Brucella Melitensis Vaccine Import & Export Trends
3.6.3 Main Sources of China Brucella Melitensis Vaccine Import
3.6.4 Export Destination of China Brucella Melitensis Vaccine
4 Brucella Melitensis Vaccine Production by Region
4.1 Global Brucella Melitensis Vaccine Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Brucella Melitensis Vaccine Manufacturers
4.3 Global Major Manufacturers, Brucella Melitensis Vaccine Capacity Expansion and Future Plans
4.4 Global Brucella Melitensis Vaccine Capacity by Region
4.5 Global Brucella Melitensis Vaccine Production by Region
4.5.1 Global Brucella Melitensis Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Brucella Melitensis Vaccine Production by Region, 2018-2023
4.5.3 Global Brucella Melitensis Vaccine Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Brucella Melitensis Vaccine Industry Chain
5.2 Brucella Melitensis Vaccine Upstream Analysis
5.2.1 Brucella Melitensis Vaccine Core Raw Materials
5.2.2 Main Manufacturers of Brucella Melitensis Vaccine Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Brucella Melitensis Vaccine Production Mode
5.6 Brucella Melitensis Vaccine Procurement Model
5.7 Brucella Melitensis Vaccine Industry Sales Model and Sales Channels
5.7.1 Brucella Melitensis Vaccine Sales Model
5.7.2 Brucella Melitensis Vaccine Typical Distributors
6 Sights by Type
6.1 Brucella Melitensis Vaccine Classification
6.1.1 Live Vaccines
6.1.2 Attenuated Vaccines
6.2 By Type, Global Brucella Melitensis Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Brucella Melitensis Vaccine Revenue, 2018-2029
6.4 By Type, Global Brucella Melitensis Vaccine Sales Volume, 2018-2029
6.5 By Type, Global Brucella Melitensis Vaccine Price, 2018-2029
7 Sights by Application
7.1 Brucella Melitensis Vaccine Segment by Application
7.1.1 Commercial Farming Enterprise
7.1.2 Private Farming
7.2 By Application, Global Brucella Melitensis Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Brucella Melitensis Vaccine Revenue, 2018-2029
7.4 By Application, Global Brucella Melitensis Vaccine Sales Volume, 2018-2029
7.5 By Application, Global Brucella Melitensis Vaccine Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Brucella Melitensis Vaccine Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Brucella Melitensis Vaccine Revenue, 2018-2029
8.3 By Region, Global Brucella Melitensis Vaccine Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Brucella Melitensis Vaccine Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Brucella Melitensis Vaccine Market Size Market Share
8.5 Europe
8.5.1 Europe Brucella Melitensis Vaccine Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Brucella Melitensis Vaccine Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Brucella Melitensis Vaccine Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Brucella Melitensis Vaccine Market Size Market Share
8.7 South America
8.7.1 South America Brucella Melitensis Vaccine Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Brucella Melitensis Vaccine Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Brucella Melitensis Vaccine Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global Brucella Melitensis Vaccine Revenue, 2018-2029
9.3 By Country, Global Brucella Melitensis Vaccine Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Brucella Melitensis Vaccine Market Size, 2018-2029
9.4.2 By Company, U.S. Brucella Melitensis Vaccine Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Brucella Melitensis Vaccine Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Brucella Melitensis Vaccine Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Brucella Melitensis Vaccine Market Size, 2018-2029
9.5.2 By Company, Europe Brucella Melitensis Vaccine Sales Volume Market Share, 2022
9.5.3 By Type, Europe Brucella Melitensis Vaccine Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Brucella Melitensis Vaccine Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Brucella Melitensis Vaccine Market Size, 2018-2029
9.6.2 By Company, China Brucella Melitensis Vaccine Sales Volume Market Share, 2022
9.6.3 By Type, China Brucella Melitensis Vaccine Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Brucella Melitensis Vaccine Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Brucella Melitensis Vaccine Market Size, 2018-2029
9.7.2 By Company, Japan Brucella Melitensis Vaccine Sales Volume Market Share, 2022
9.7.3 By Type, Japan Brucella Melitensis Vaccine Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Brucella Melitensis Vaccine Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Brucella Melitensis Vaccine Market Size, 2018-2029
9.8.2 By Company, South Korea Brucella Melitensis Vaccine Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Brucella Melitensis Vaccine Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Brucella Melitensis Vaccine Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Brucella Melitensis Vaccine Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Brucella Melitensis Vaccine Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Brucella Melitensis Vaccine Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Brucella Melitensis Vaccine Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Brucella Melitensis Vaccine Market Size, 2018-2029
9.10.2 By Company, India Brucella Melitensis Vaccine Sales Volume Market Share, 2022
9.10.3 By Type, India Brucella Melitensis Vaccine Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Brucella Melitensis Vaccine Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Brucella Melitensis Vaccine Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Brucella Melitensis Vaccine Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Brucella Melitensis Vaccine Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Brucella Melitensis Vaccine Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 CZ Veterinaria
10.1.1 CZ Veterinaria Company Information, Head Office, Market Area and Industry Position
10.1.2 CZ Veterinaria Brucella Melitensis Vaccine Models, Specifications and Application
10.1.3 CZ Veterinaria Brucella Melitensis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 CZ Veterinaria Company Profile and Main Business
10.1.5 CZ Veterinaria Recent Developments
10.2 JOVAC
10.2.1 JOVAC Company Information, Head Office, Market Area and Industry Position
10.2.2 JOVAC Brucella Melitensis Vaccine Models, Specifications and Application
10.2.3 JOVAC Brucella Melitensis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 JOVAC Company Profile and Main Business
10.2.5 JOVAC Recent Developments
10.3 Dollvet
10.3.1 Dollvet Company Information, Head Office, Market Area and Industry Position
10.3.2 Dollvet Brucella Melitensis Vaccine Models, Specifications and Application
10.3.3 Dollvet Brucella Melitensis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Dollvet Company Profile and Main Business
10.3.5 Dollvet Recent Developments
10.4 Antigen
10.4.1 Antigen Company Information, Head Office, Market Area and Industry Position
10.4.2 Antigen Brucella Melitensis Vaccine Models, Specifications and Application
10.4.3 Antigen Brucella Melitensis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Antigen Company Profile and Main Business
10.4.5 Antigen Recent Developments
10.5 Jinyu
10.5.1 Jinyu Company Information, Head Office, Market Area and Industry Position
10.5.2 Jinyu Brucella Melitensis Vaccine Models, Specifications and Application
10.5.3 Jinyu Brucella Melitensis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Jinyu Company Profile and Main Business
10.5.5 Jinyu Recent Developments
10.6 Onderstepoort
10.6.1 Onderstepoort Company Information, Head Office, Market Area and Industry Position
10.6.2 Onderstepoort Brucella Melitensis Vaccine Models, Specifications and Application
10.6.3 Onderstepoort Brucella Melitensis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Onderstepoort Company Profile and Main Business
10.6.5 Onderstepoort Recent Developments
10.7 VETAL Animal Health Products Inc.
10.7.1 VETAL Animal Health Products Inc. Company Information, Head Office, Market Area and Industry Position
10.7.2 VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Models, Specifications and Application
10.7.3 VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 VETAL Animal Health Products Inc. Company Profile and Main Business
10.7.5 VETAL Animal Health Products Inc. Recent Developments
10.8 MSD Animal Health
10.8.1 MSD Animal Health Company Information, Head Office, Market Area and Industry Position
10.8.2 MSD Animal Health Brucella Melitensis Vaccine Models, Specifications and Application
10.8.3 MSD Animal Health Brucella Melitensis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 MSD Animal Health Company Profile and Main Business
10.8.5 MSD Animal Health Recent Developments
10.9 Hester Biosciences Limited
10.9.1 Hester Biosciences Limited Company Information, Head Office, Market Area and Industry Position
10.9.2 Hester Biosciences Limited Brucella Melitensis Vaccine Models, Specifications and Application
10.9.3 Hester Biosciences Limited Brucella Melitensis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Hester Biosciences Limited Company Profile and Main Business
10.9.5 Hester Biosciences Limited Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Brucella Melitensis Vaccine Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Brucella Melitensis Vaccine Market Restraints
Table 3. Brucella Melitensis Vaccine Market Trends
Table 4. Brucella Melitensis Vaccine Industry Policy
Table 5. Global Brucella Melitensis Vaccine Revenue by Company, 2018-2023, US$ million
Table 6. Global Brucella Melitensis Vaccine Revenue Market Share by Company, 2018-2023
Table 7. Global Brucella Melitensis Vaccine Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Brucella Melitensis Vaccine Sales Volume Market Share by Company, 2018-2023
Table 9. Global Brucella Melitensis Vaccine Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Brucella Melitensis Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Brucella Melitensis Vaccine Mergers & Acquisitions, Expansion Plans
Table 12. Global Brucella Melitensis Vaccine Manufacturers Product Type
Table 13. China Brucella Melitensis Vaccine Revenue by Company, 2018-2023, US$ million
Table 14. China Brucella Melitensis Vaccine Revenue Market Share by Company, 2018-2023
Table 15. China Brucella Melitensis Vaccine Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Brucella Melitensis Vaccine Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Brucella Melitensis Vaccine Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Brucella Melitensis Vaccine Import & Export Trends
Table 19. Main Sources of China Brucella Melitensis Vaccine Import
Table 20. Export Destination of China Brucella Melitensis Vaccine
Table 21. Global Headquarters and Manufacturing Base of Brucella Melitensis Vaccine Manufacturers
Table 22. Global Major Manufacturers, Brucella Melitensis Vaccine Capacity Expansion and Future Plans
Table 23. Global Brucella Melitensis Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Brucella Melitensis Vaccine Production by Region, 2018-2023, (K Units)
Table 25. Global Brucella Melitensis Vaccine Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Brucella Melitensis Vaccine Upstream (Raw Materials)
Table 27. Global Brucella Melitensis Vaccine Typical Customers
Table 28. Brucella Melitensis Vaccine Typical Distributors
Table 29. By Type, Global Brucella Melitensis Vaccine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Brucella Melitensis Vaccine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Brucella Melitensis Vaccine Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Brucella Melitensis Vaccine Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Brucella Melitensis Vaccine Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Brucella Melitensis Vaccine Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Brucella Melitensis Vaccine Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Brucella Melitensis Vaccine Revenue Market Share, 2018-2029
Table 37. By Country, Global Brucella Melitensis Vaccine Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Brucella Melitensis Vaccine Sales Volume Market Share, 2018-2029
Table 39. CZ Veterinaria Company Information, Head Office, Market Area and Industry Position
Table 40. CZ Veterinaria Brucella Melitensis Vaccine Models, Specifications and Application
Table 41. CZ Veterinaria Brucella Melitensis Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. CZ Veterinaria Company Profile and Main Business
Table 43. CZ Veterinaria Recent Developments
Table 44. JOVAC Company Information, Head Office, Market Area and Industry Position
Table 45. JOVAC Brucella Melitensis Vaccine Models, Specifications and Application
Table 46. JOVAC Brucella Melitensis Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. JOVAC Company Profile and Main Business
Table 48. JOVAC Recent Developments
Table 49. Dollvet Company Information, Head Office, Market Area and Industry Position
Table 50. Dollvet Brucella Melitensis Vaccine Models, Specifications and Application
Table 51. Dollvet Brucella Melitensis Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Dollvet Company Profile and Main Business
Table 53. Dollvet Recent Developments
Table 54. Antigen Company Information, Head Office, Market Area and Industry Position
Table 55. Antigen Brucella Melitensis Vaccine Models, Specifications and Application
Table 56. Antigen Brucella Melitensis Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Antigen Company Profile and Main Business
Table 58. Antigen Recent Developments
Table 59. Jinyu Company Information, Head Office, Market Area and Industry Position
Table 60. Jinyu Brucella Melitensis Vaccine Models, Specifications and Application
Table 61. Jinyu Brucella Melitensis Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Jinyu Company Profile and Main Business
Table 63. Jinyu Recent Developments
Table 64. Onderstepoort Company Information, Head Office, Market Area and Industry Position
Table 65. Onderstepoort Brucella Melitensis Vaccine Models, Specifications and Application
Table 66. Onderstepoort Brucella Melitensis Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Onderstepoort Company Profile and Main Business
Table 68. Onderstepoort Recent Developments
Table 69. VETAL Animal Health Products Inc. Company Information, Head Office, Market Area and Industry Position
Table 70. VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Models, Specifications and Application
Table 71. VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. VETAL Animal Health Products Inc. Company Profile and Main Business
Table 73. VETAL Animal Health Products Inc. Recent Developments
Table 74. MSD Animal Health Company Information, Head Office, Market Area and Industry Position
Table 75. MSD Animal Health Brucella Melitensis Vaccine Models, Specifications and Application
Table 76. MSD Animal Health Brucella Melitensis Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. MSD Animal Health Company Profile and Main Business
Table 78. MSD Animal Health Recent Developments
Table 79. Hester Biosciences Limited Company Information, Head Office, Market Area and Industry Position
Table 80. Hester Biosciences Limited Brucella Melitensis Vaccine Models, Specifications and Application
Table 81. Hester Biosciences Limited Brucella Melitensis Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Hester Biosciences Limited Company Profile and Main Business
Table 83. Hester Biosciences Limited Recent Developments
List of Figure
Figure 1. Brucella Melitensis Vaccine Picture
Figure 2. By Revenue, Global Brucella Melitensis Vaccine Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Brucella Melitensis Vaccine Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Brucella Melitensis Vaccine Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Brucella Melitensis Vaccine Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Brucella Melitensis Vaccine Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Brucella Melitensis Vaccine Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Brucella Melitensis Vaccine Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Brucella Melitensis Vaccine Share of Global Market, 2018-2029
Figure 10. Global Brucella Melitensis Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Brucella Melitensis Vaccine Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Brucella Melitensis Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Brucella Melitensis Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Brucella Melitensis Vaccine Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Brucella Melitensis Vaccine Domestic VS Export, 2022
Figure 16. Global Brucella Melitensis Vaccine Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Brucella Melitensis Vaccine Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Brucella Melitensis Vaccine Production Market Share & Forecast by Region, 2018-2029
Figure 19. Brucella Melitensis Vaccine Industry Chain
Figure 20. Brucella Melitensis Vaccine Procurement Model
Figure 21. Brucella Melitensis Vaccine Sales Model
Figure 22. Brucella Melitensis Vaccine Sales Channels, Direct Sales and Distribution
Figure 23. Live Vaccines
Figure 24. Attenuated Vaccines
Figure 25. By Type, Global Brucella Melitensis Vaccine Revenue, 2018-2029, US$ Million
Figure 26. By Type, Global Brucella Melitensis Vaccine Revenue Market Share, 2018-2029
Figure 27. By Type, Global Brucella Melitensis Vaccine Sales Volume, 2018-2029, (K Units)
Figure 28. By Type, Global Brucella Melitensis Vaccine Sales Volume Market Share, 2018-2029
Figure 29. By Type, Global Brucella Melitensis Vaccine Price, 2018-2029, (US$/Unit)
Figure 30. Commercial Farming Enterprise
Figure 31. Private Farming
Figure 32. By Application, Global Brucella Melitensis Vaccine Revenue, 2018-2029, US$ Million
Figure 33. By Application, Global Brucella Melitensis Vaccine Revenue Market Share, 2018-2029
Figure 34. By Application, Global Brucella Melitensis Vaccine Sales Volume, 2018-2029, (K Units)
Figure 35. By Application, Global Brucella Melitensis Vaccine Sales Volume Market Share, 2018-2029
Figure 36. By Application, Global Brucella Melitensis Vaccine Price, 2018-2029, (US$/Unit)
Figure 37. By Region, Global Brucella Melitensis Vaccine Revenue Market Share, 2018-2029
Figure 38. By Region, Global Brucella Melitensis Vaccine Sales Volume Market Share, 2018-2029
Figure 39. North America Brucella Melitensis Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, North America Brucella Melitensis Vaccine Revenue Market Share, 2022
Figure 41. Europe Brucella Melitensis Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, Europe Brucella Melitensis Vaccine Revenue Market Share, 2022
Figure 43. Asia Pacific Brucella Melitensis Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country/Region, Asia Pacific Brucella Melitensis Vaccine Revenue Market Share, 2022
Figure 45. South America Brucella Melitensis Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, South America Brucella Melitensis Vaccine Revenue Market Share, 2022
Figure 47. Middle East & Africa Brucella Melitensis Vaccine Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. U.S. Brucella Melitensis Vaccine Sales Volume, 2018-2029, (K Units)
Figure 49. By Company, U.S. Brucella Melitensis Vaccine Market Share, 2022
Figure 50. By Type, U.S. Brucella Melitensis Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 51. By Application, U.S. Brucella Melitensis Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 52. Europe Brucella Melitensis Vaccine Sales Volume, 2018-2029, (K Units)
Figure 53. By Company, Europe Brucella Melitensis Vaccine Market Share, 2022
Figure 54. By Type, Europe Brucella Melitensis Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 55. By Application, Europe Brucella Melitensis Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 56. China Brucella Melitensis Vaccine Sales Volume, 2018-2029, (K Units)
Figure 57. By Company, China Brucella Melitensis Vaccine Market Share, 2022
Figure 58. By Type, China Brucella Melitensis Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 59. By Application, China Brucella Melitensis Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 60. Japan Brucella Melitensis Vaccine Sales Volume, 2018-2029, (K Units)
Figure 61. By Company, Japan Brucella Melitensis Vaccine Market Share, 2022
Figure 62. By Type, Japan Brucella Melitensis Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 63. By Application, Japan Brucella Melitensis Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 64. South Korea Brucella Melitensis Vaccine Sales Volume, 2018-2029, (K Units)
Figure 65. By Company, South Korea Brucella Melitensis Vaccine Market Share, 2022
Figure 66. By Type, South Korea Brucella Melitensis Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 67. By Application, South Korea Brucella Melitensis Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 68. Southeast Asia Brucella Melitensis Vaccine Sales Volume, 2018-2029, (K Units)
Figure 69. By Company, Southeast Asia Brucella Melitensis Vaccine Market Share, 2022
Figure 70. By Type, Southeast Asia Brucella Melitensis Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 71. By Application, Southeast Asia Brucella Melitensis Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 72. India Brucella Melitensis Vaccine Sales Volume, 2018-2029, (K Units)
Figure 73. By Company, India Brucella Melitensis Vaccine Market Share, 2022
Figure 74. By Type, India Brucella Melitensis Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 75. By Application, India Brucella Melitensis Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 76. Middle East & Asia Brucella Melitensis Vaccine Sales Volume, 2018-2029, (K Units)
Figure 77. By Company, Middle East & Asia Brucella Melitensis Vaccine Market Share, 2022
Figure 78. By Type, Middle East & Asia Brucella Melitensis Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 79. By Application, Middle East & Asia Brucella Melitensis Vaccine Sales Volume Market Share, 2022 VS 2029
Figure 80. Research Methodology
Figure 81. Breakdown of Primary Interviews
Figure 82. Bottom-up Approaches
Figure 83. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|